Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
about
Venovenous Extracorporeal Membrane Oxygenation in Intractable Pulmonary Insufficiency: Practical Issues and Future DirectionsBivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDo we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features.Platelet adhesion under flow.Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein CPharmacology and clinical applications of human recombinant antithrombin.Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal Coating™.Polyphosphate multi-tasks.Preparation and evaluation of a novel oral delivery system for low molecular weight heparin.von Willebrand factor: biological function and molecular defects.Low-molecular-weight heparins for acute coronary syndromes.Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.The importance of von Willebrand factor level and heart rate changes in acute coronary syndromes: a comparison with chronic ischemic conditions.Binding of von Willebrand factor to the small proteoglycan decorin.Heparin therapy leads to platelet activation and prolongation of PFA-100 closure time.Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics.Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
P2860
Q26748920-2D706A4F-5E21-4B45-AF0A-94030565A355Q33393161-E56D1AD9-75D8-40B4-A320-CED7DB4495DCQ33399576-A7521967-84D2-4C9D-BAE7-04856FBE1A8BQ33416578-A1D1DBB0-E175-4E50-966B-888B5400414BQ33931454-3ED52EDB-1AC8-47A4-9304-CBC6605BDD5CQ34673739-D9DAF37C-14D8-4ACA-BBF0-B3AC12C7EC58Q37368145-1FD537C1-42CD-4057-B9D9-B7EACB252E80Q37763191-DB167245-72C3-4523-A86E-1B1D945E9754Q38145381-7707816E-CC57-4936-AD4B-E9233DD4D20DQ38191251-CF6C5CD9-2102-4D70-B253-43E9FD2640B5Q41119921-907AF2F9-2FEF-4844-BEBF-6313C4EF5705Q41323819-1BE5C823-F249-4451-86F5-52C98195E859Q41550747-6659A2AD-8C24-42E7-920B-B83A20770717Q41651628-D1D694C9-92FE-4388-9CAE-4C52542DCC7DQ41707230-A4683F77-BF40-4A9F-9956-6190C911051AQ42320921-52B6ED9A-568A-4698-BCFC-E5990A0BCF6EQ44464686-5E6938B5-FC91-47A8-88C0-B9CFA7F8AED5Q45052637-DB5A7735-EC27-4A09-B3E6-CACE3F02854DQ46871294-826215ED-3A8E-4086-BF16-58118E5D1B23Q47175046-C3D58807-3A78-4F84-A8E1-28726ED69BA1Q53473754-C3C514CD-3C30-4E41-A73E-F49870176707Q58710868-5BC9AF43-9FCF-4963-B661-0551DDA42E04
P2860
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Heparin inhibition of von Will ...... function in vitro and in vivo.
@ast
Heparin inhibition of von Will ...... function in vitro and in vivo.
@en
Heparin inhibition of von Will ...... function in vitro and in vivo.
@nl
type
label
Heparin inhibition of von Will ...... function in vitro and in vivo.
@ast
Heparin inhibition of von Will ...... function in vitro and in vivo.
@en
Heparin inhibition of von Will ...... function in vitro and in vivo.
@nl
prefLabel
Heparin inhibition of von Will ...... function in vitro and in vivo.
@ast
Heparin inhibition of von Will ...... function in vitro and in vivo.
@en
Heparin inhibition of von Will ...... function in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Heparin inhibition of von Will ...... function in vitro and in vivo.
@en
P2093
J C Kermode
P L Carlson
P M McNeill
P2860
P304
P356
10.1172/JCI115198
P407
P577
1991-05-01T00:00:00Z